Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPD
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine the percentage of patients with
"therapeutic success" at the end of the cycle of antibiotic therapy (10 days), in the two
treatment groups (levofloxacin and prulifloxacin). The effect of study treatments will be
evaluated on the basis of a score determined in relation to the signs-symptoms of acute
exacerbation of COPD (sputum purulence, sputum volume, cough, dyspnea, fever)